|
1
|
Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP,
Chang FY, Chiang JH, Lui WY, Chu CW and Lee SD: Clinical
characteristics and prognosis of hepatocellular carcinoma patients
with paraneoplastic syndromes. Hepatogastroenterology.
49:1315–1319. 2002.PubMed/NCBI
|
|
2
|
Eastman RC, Carson RE, Orloff DG, Cochran
CS, Perdue JF, Rechler MM, Lanau F, Roberts CT Jr, Shapiro J, Roth
J, et al: Glucose utilization in a patient with hepatoma and
hypoglycemia. Assessment by a positron emission tomography. J Clin
Invest. 89:1958–1963. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tietge UJ, Schöfl C, Ocran KW, Wagner S,
Böker KH, Brabant G, Zapf J and Manns MP: Hepatoma with severe
non-islet cell tumor hypoglycemia. Am J Gastroenterol. 93:997–1000.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scott K: Non-islet cell tumor
hypoglycemia. J Pain Symptom Manage. 37:e1–e3. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kahn CR: The riddle of tumour
hypoglycaemia revisited. Clin Endocrinol Metab. 9:335–360. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrides AS and DeFronzo RA: Glucose
metabolism in cirrhosis: a review with some perspectives for the
future. Diabetes Metab Rev. 5:691–709. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalebi AY, Hale MJ, Wong ML, Hoffman T and
Murray J: Surgically cured hypoglycemia secondary to pleural
solitary fibrous tumour: case report and update review on the
Doege-Potter syndrome. J Cardiothorac Surg. 4:452009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park MS and Araujo DM: New insights into
the hemangiopericytoma/solitary fibrous tumor spectrum of tumors.
Curr Opin Oncol. 21:327–331. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perros P, Simpson J, Innes JA, Teale JD
and McKnight JA: Non-islet cell tumour-associated hypoglycaemia:
111In-octreotide imaging and efficacy of octreotide, growth hormone
and glucocorticosteroids. Clin Endocrinol (Oxf). 44:727–731. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saigal S, Nandeesh HP, Malhotra V and
Sarin SK: A case of hepatocellular carcinoma associated with
troublesome hypoglycemia: management by cytoreduction using
percutaneous ethanol injection. Am J Gastroenterol. 93:1380–1381.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hunter SJ, Daughaday WH, Callender ME,
McKnight JA, McIlrath EM, Teale JD and Atkinson AB: A case of
hepatoma associated with hypoglycaemia and overproduction of IGF-II
(E-21): beneficial effects of treatment with growth hormone and
intrahepatic adriamycin. Clin Endocrinol (Oxf). 41:397–401.
1994.discussion 402. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin S, Bai Y, Lim HY, Thongprasert S, Chao
Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, et al:
Randomized, multicenter, open-label study of oxaliplatin plus
fluorouracil/leucovorin versus doxorubicin as palliative
chemotherapy in patients with advanced hepatocellular carcinoma
from Asia. J Clin Oncol. 31:3501–3508. 2013. View Article : Google Scholar : PubMed/NCBI
|
